Literature DB >> 25187662

Latent infection with cytomegalovirus is associated with poor memory CD4 responses to influenza A core proteins in the elderly.

Evelyna Derhovanessian1, Andrea B Maier2, Karin Hähnel3, Janet E McElhaney4, Eline P Slagboom5, Graham Pawelec3.   

Abstract

Influenza remains a major pathogen in older people. Infection with CMV and the accumulation of late-differentiated T cells associated with it have been implicated in poor Ab responsiveness to influenza vaccination in the elderly, most of whom are CMV positive. However, whether CMV infection also affects memory T cell responses to influenza remains unknown. To investigate this, we assessed T cell responses to influenza A matrix protein and nucleoprotein ex vivo in 166 Dutch individuals (mean age 62.2 y, range 42-82) and validated the results in a second cohort from North America (mean age 73.1 y, range 65-81, n = 28). We found that less than half of the CMV-infected older subjects mounted a CD4 T cell response to influenza Ags, whereas ∼80% of uninfected elderly did so. A similar proportion of younger subjects possessed influenza A virus-responsive CD4 T cells, and, interestingly, this was the case whether they were CMV-infected. Thus, the effect of CMV was only seen in the older donors, who may have been exposed to the virus for decades. The percentage of donors with CD8 responses to influenza A virus was lower than those with CD4; this was not influenced by whether the subjects were CMV seropositive or seronegative. CMV-seropositive responders had significantly higher frequencies of late-differentiated CD4 T-cells (CD45RA(+/-)CCR7(-)CD27(-)CD28(-)) compared with CMV-infected nonresponders. These data add to the accumulating evidence that infection with CMV has profound but heterogeneous effects on responses to the products of other viruses and have implications for the design of influenza vaccines, especially in the elderly.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25187662     DOI: 10.4049/jimmunol.1303361

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

Review 1.  Aging, cytomegalovirus (CMV) and influenza vaccine responses.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

Review 2.  Sex and Gender Impact Immune Responses to Vaccines Among the Elderly.

Authors:  Ashley L Fink; Sabra L Klein
Journal:  Physiology (Bethesda)       Date:  2015-11

3.  Telomere Length as an Indicator of the Robustness of B- and T-Cell Response to Influenza in Older Adults.

Authors:  Kevin Najarro; Huy Nguyen; Guobing Chen; Mai Xu; Sandy Alcorta; Xu Yao; Linda Zukley; E Jeffrey Metter; Thai Truong; Yun Lin; Huifen Li; Mathias Oelke; Xiyan Xu; Shari M Ling; Dan L Longo; Jonathan Schneck; Sean Leng; Luigi Ferrucci; Nan-ping Weng
Journal:  J Infect Dis       Date:  2015-03-31       Impact factor: 5.226

4.  How does cytomegalovirus factor into diseases of aging and vaccine responses, and by what mechanisms?

Authors:  Allison E Aiello; Yen-Ling Chiu; Daniela Frasca
Journal:  Geroscience       Date:  2017-06-18       Impact factor: 7.713

Review 5.  The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer.

Authors:  Xiao-Hua Luo; Qingda Meng; Martin Rao; Zhenjiang Liu; Georgia Paraschoudi; Ernest Dodoo; Markus Maeurer
Journal:  Immunology       Date:  2018-09-10       Impact factor: 7.397

6.  B Cell-Specific Biomarkers for Optimal Antibody Responses to Influenza Vaccination and Molecular Pathways That Reduce B Cell Function with Aging.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

7.  Defining the effects of age and gender on immune response and outcomes to melanoma vaccination: a retrospective analysis of a single-institution clinical trials' experience.

Authors:  Adriana G Ramirez; Nolan A Wages; Yinin Hu; Mark E Smolkin; Craig L Slingluff
Journal:  Cancer Immunol Immunother       Date:  2015-09-21       Impact factor: 6.968

8.  Understanding the mechanism of action of cytomegalovirus-induced regulatory T cells.

Authors:  Adriana Tovar-Salazar; Adriana Weinberg
Journal:  Virology       Date:  2020-05-10       Impact factor: 3.616

Review 9.  Cytomegalovirus Vaccines: Current Status and Future Prospects.

Authors:  K M Anderholm; C J Bierle; M R Schleiss
Journal:  Drugs       Date:  2016-11       Impact factor: 9.546

Review 10.  Inflammaging decreases adaptive and innate immune responses in mice and humans.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Biogerontology       Date:  2015-04-29       Impact factor: 4.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.